ESPR Stock Price History and Quote Analysis Insights for Investors
Esperion Therapeutics, Inc.
Stock Price Today
Esperion Therapeutics, Inc. (ESPR) stock declined over -11.76%, trading at $2.25 on NASDAQ, down from the previous close of $2.55. The stock opened at $2.18, fluctuating between $1.84 and $2.27 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Company Information
| Employees | 240 |
| Beta | 0.95 |
| Sales or Revenue | $116.33M |
| 5Y Sales Change% | -0.836% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Esperion Therapeutics, Inc. (NASDAQ: ESPR) stock price is $2.25 in the last trading session. During the trading session, ESPR stock reached the peak price of $2.27 while $1.84 was the lowest point it dropped to. The percentage change in ESPR stock occurred in the recent session was -11.76% while the dollar amount for the price change in ESPR stock was -$0.30.
The NASDAQ listed ESPR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Esperion Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Tiffany Aldrich M.B.A.
Associate Director of Corporation Communications
Mr. Ben Halladay M.B.A.
Chief Financial Officer
Mr. Kenneth J. Fiorelli
Chief Technical Operations Officer
Mr. Eric J. Warren R.Ph.
Chief Commercial Officer
Mr. Benjamin O. Looker
Gen. Counsel
Mr. Sheldon L. Koenig
Pres, Chief Executive Officer & Director
Ms. Betty Jean Swartz
Chief Strategy Officer
Mr. Benjamin Halladay M.B.A.
Chief Financial Officer
Dr. JoAnne Micale Foody FACC, M.D.
Chief Medical Officer
Mr. Glenn P. Brame
Chief Technical Operations Officer
ESPR's closing price is 42.41% higher than its 52-week low of $1.58 where as its distance from 52-week high of $3.94 is -42.89%.
Number of ESPR employees currently stands at 240.
Official Website of ESPR is: https://www.esperion.com
ESPR could be contacted at phone 734 887 3903 and can also be accessed through its website. ESPR operates from 3891 Ranchero Drive, Ann Arbor, MI 48108, United States.
ESPR stock volume for the day was 33.87M shares. The average number of ESPR shares traded daily for last 3 months was 4.96M.
The market value of ESPR currently stands at $443.33M with its latest stock price at $2.25 and 197.04M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com